Shares of LexaGene Holdings Inc. (CVE:LXG – Get Free Report) fell 19.2% during trading on Thursday . The company traded as low as C$0.10 and last traded at C$0.11. 2,135,375 shares traded hands during trading, an increase of 1,156% from the average session volume of 170,061 shares. The stock had previously closed at C$0.13.
LexaGene Stock Performance
The company has a debt-to-equity ratio of 138.01, a current ratio of 1.39 and a quick ratio of 1.13. The stock’s 50-day simple moving average is C$0.11 and its 200 day simple moving average is C$0.11. The stock has a market capitalization of C$14.77 million, a P/E ratio of -1.31 and a beta of 2.26.
LexaGene Company Profile
LexaGene Holdings Inc, a biotechnology company, engages in the research, development, and commercialization of pathogen detection systems. It offers MiQLab, an automated pathogen detection system that aims to transform pathogen detection in veterinary diagnostics, human clinical diagnostics, food and water safety testing, and other life sciences markets.
Featured Stories
- Five stocks we like better than LexaGene
- How to invest in marijuana stocks in 7 steps
- Why Palo Alto Networks’ Multi-Year Uptrend Is Far From Over
- Insider Trades May Not Tell You What You Think
- 3 Rock-Solid Buying Opportunities in the Market Right Now
- 3 REITs to Buy and Hold for the Long Term
- TJX Companies Stock Poised to Hit a New High This Year
Receive News & Ratings for LexaGene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LexaGene and related companies with MarketBeat.com's FREE daily email newsletter.
